Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function
Authors:
- 15 August 2022
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 358, 12-28
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- A Novel RhoA/ROCK-CPI-17-MEF2C Signaling Pathway Regulates Vascular Smooth Muscle Cell Gene ExpressionJournal of Biological Chemistry, 2012
- Role for miR-204 in human pulmonary arterial hypertensionJournal of Experimental Medicine, 2011
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Disruption of actin cytoskeleton mediates loss of tensile stress induced early phenotypic modulation of vascular smooth muscle cells in organ cultureExperimental and Molecular Pathology, 2009
- Monocyte-Endothelial Cell Interactions in the Development of AtherosclerosisTrends in Cardiovascular Medicine, 2008
- The early- and late stages in phenotypic modulation of vascular smooth muscle cells: Differential roles for lysophosphatidic acidBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- TGF-β1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60c-src/EGFRY845 and Rho/ROCK signalingJournal of Molecular and Cellular Cardiology, 2008
- Phosphorylation-Induced Conformational Switching of CPI-17 Produces a Potent Myosin Phosphatase InhibitorStructure, 2007
- Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractilityJournal of Cell Biology, 2006
- FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassemblyNature Cell Biology, 2004